Diphenhydramine

Diphenhydramine
Clinical data
Pronunciation/ˌdfɛnˈhdrəmn/
Trade namesBenadryl, Unisom, Nytol, others
AHFS/Drugs.comMonograph
MedlinePlusa682539
License data
Pregnancy
category
  • AU: A
Dependence
liability
Low
Routes of
administration
By mouth, intramuscular, intravenous, topical, rectal
Drug classFirst-generation antihistamine, antimuscarinic, hallucinogen (deliriant)
ATC code
Legal status
Legal status
  • AU: S4 (Prescription only) / S2 (Pharmacy Medicine) / S3 (Pharmacist Only Medicine)
  • CA: OTC
  • UK: P (Pharmacy medicines)
  • US: OTC / Rx-only
  • UN: Unscheduled
Pharmacokinetic data
Bioavailability40–60%
Protein binding98–99%
MetabolismLiver (CYP2D6, others)
Elimination half-lifeRange: 2.4–13.5 h
ExcretionUrine: 94%
Feces: 6%
Identifiers
  • 2-(diphenylmethoxy)-N,N-dimethylethanamine
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.000.360
Chemical and physical data
FormulaC17H21NO
Molar mass255.361 g·mol−1
3D model (JSmol)
  • O(CCN(C)C)C(c1ccccc1)c2ccccc2
  • InChI=1S/C17H21NO/c1-18(2)13-14-19-17(15-9-5-3-6-10-15)16-11-7-4-8-12-16/h3-12,17H,13-14H2,1-2H3 Y
  • Key:ZZVUWRFHKOJYTH-UHFFFAOYSA-N Y
 NY (what is this?)  (verify)

Diphenhydramine, sold under the brand name Benadryl among others, is an antihistamine and sedative. Although generally considered sedating, diphenhydramine can cause paradoxical central nervous system stimulation in some individuals, particularly at higher doses. This may manifest as agitation, anxiety, or restlessness rather than sedation. It is a first-generation H1-antihistamine and it works by blocking certain effects of histamine, which produces its antihistamine and sedative effects. Diphenhydramine is also a potent anticholinergic. It is mainly used to treat allergies, insomnia, and symptoms of the common cold. It is also less commonly used for tremors in parkinsonism, and nausea. It is taken by mouth, injected into a vein, injected into a muscle, or applied to the skin. Maximal effect is typically around two hours after a dose, and effects can last for up to seven hours.

Common side effects include sleepiness, poor coordination, and an upset stomach. There is no clear risk of harm when used during pregnancy; however, use during breastfeeding is not recommended.

It was developed by George Rieveschl and put into commercial use in 1946. It is available as a generic medication. In 2022, it was the 258th most commonly prescribed medication in the United States, with more than 1 million prescriptions.

Its sedative and deliriant effects have led to some cases of recreational use.